scispace - formally typeset
M

Maria M. Picken

Researcher at Loyola University Medical Center

Publications -  204
Citations -  9409

Maria M. Picken is an academic researcher from Loyola University Medical Center. The author has contributed to research in topics: Renal cell carcinoma & Amyloidosis. The author has an hindex of 50, co-authored 186 publications receiving 8449 citations. Previous affiliations of Maria M. Picken include Loyola University Chicago & Indiana University – Purdue University Indianapolis.

Papers
More filters
Journal ArticleDOI

The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

John R. Srigley, +134 more
TL;DR: The classification working group of the International Society of Urological Pathology consensus conference on renal neoplasia was in charge of making recommendations regarding additions and changes to the current World Health Organization Classification of Renal Tumors, with consensus that 5 entities should be recognized as new distinct epithelial tumors within the classification system.
Journal ArticleDOI

The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

Brett Delahunt, +131 more
TL;DR: The International Society of Urological Pathology 2012 Consensus Conference made recommendations regarding classification, prognostic factors, staging, and immunohistochemical and molecular assessment of adult renal tumors.
Journal ArticleDOI

Human polyoma virus-associated interstitial nephritis in the allograft kidney

TL;DR: Polyoma virus tubulo-interstitial nephritis-associated graft dysfunction usually calls for judicious decrease in immunosuppression and monitoring for acute rejection, and development of methods to serially quantify the viral load in individual patients could potentially improve clinical outcome.
Journal ArticleDOI

Metastatic renal cell carcinoma

TL;DR: Recent advances in biologic response modifier therapy have brought new hope to a small percentage of patients who respond to this therapy and rekindled interest in cytoreductive nephrectomy as an integral part of the management of these patients.